DOI QR코드

DOI QR Code

Studies on the Oral Disease Improvement Effects of Probiotics : A Review

프로바이오틱스의 구강질병 개선에 관한 연구 고찰

  • Chung, Sung-Kyun (Department of Dental Hygiene, College of Health Science, Shinhan University)
  • 정성균 (신한대학교 보건과학대학 치위생학과)
  • Received : 2019.05.01
  • Accepted : 2019.06.20
  • Published : 2019.06.28

Abstract

This study is a review of research articles on the characteristics of probiotics. Probiotics are effective at ameliorating immune disease, alleviating glucose intolerance, and improving constipation and diarrhea. Furthermore, they have anticancer and antitumor effects, preventive effects against cardiovascular disease, antidiabetic effects, antioxidant effects, antibacterial effects, and they produce useful metabolites. It has been demonstrated that oral probiotics are effective in eliminating halitosis and forming a favorable oral ecosystem, by creating an environment that is not readily inhabited by harmful bacteria, such as Streptococcus mutans, which produces lactic acid and causes tooth decay, or Porphyromonas gingivalis, which causes gum disease.As a result, oral probiotics are being considered not only as therapeutics against diseases, but also as preventive agents for the maintenance of a healthy oral balance. In spite of some limitations, clinical trials are currently underway, and this study can provide evidence to support the use of probiotics to improve oral health conditions, including dental caries, periodontal disease, and Candida colonization.

본 연구는 프로바이오틱스의 특성과 관련 연구에 대한 종설이다. 프로바이오틱스는 면역질환 개선 효과, 유당불내증 완화 효과, 변비 및 설사 개선 효과, 항암 및 항종양 효과, 심혈관계 질환 예방 효과, 항당뇨 효과, 항산화 효과, 항균효과, 유용 대사산물의 생산 등의 기능성을 입증하였다. 구강 프로바이오틱스는 젖산을 생성하여 충치의 원인이 되는 뮤탄스균과 잇몸 질환을 일으키는 진지발리스균을 비롯한 유해균이 서식하기 어려운 환경을 만들어 구강 생태계 조성과 구취 제거에 효과적이라는 연구가 입증되었다. 그 결과 질환 완화는 물론 건강한 구강 밸런스를 관리하는 예방법으로 주목받고 있다. 일부 제한점에도 불구하고 현재 유용한 임상연구가 진행되고 있으며, 본 연구는 치아우식증과 치주염, 칸디다의 집락화 등 구강상태를 개선하기 위한 프로바이오틱스의 근거가 될 수 있을 것이다.

Keywords

DJTJBT_2019_v17n6_315_f0001.png 이미지

Fig. 1. Schematic diagram illustrating potential or known mechanisms of the impact of probiotic bacteriaon the microbiota.

Table 1. Different types of probiotic microbial strains, and their usage.

DJTJBT_2019_v17n6_315_t0001.png 이미지

References

  1. NIH Human Microbiome Portfolio Analysis Team. (2019). A review of 10 years of human microbiome research activities at the US National Institutes of Health, fiscal years 2007-2016. Microbiome, 7(1), 31-49. DOI : 10.1186/s40168-019-0620-y
  2. L. Vigano, S. Ferraro, C. Casu & M. Fanuli. (2018). The oral microbiome in the context of aging and cognitive impairment. Acta Scientific Microbiology, 1(8), 17-22. https://doi.org/10.31080/ASMI.2018.01.0013
  3. I. Cho & M. J. Blaser. (2012). The human microbiome: at the interface of health and disease. Nature reviews. Genetics, 13(4), 260-270. DOI : 10.1038/nrg3182
  4. M. F. Zarco, T. J. Vess & G. S. Ginsburg. (2012). The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral diseases, 18(2), 109-120. DOI : 10.1111/j.1601-0825.2011.01851.x
  5. M. J. Butel. (2014). Probiotics, gut microbiota and health. Medecine et Maladies Infectieuses, 44(1), 1-8. DOI : 10.1016/j.medmal.2013.10.002
  6. A. J. Ahola et al. (2002). Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. Archives of oral biology, 47(11), 799-804. DOI : 10.1016/S0003-9969(02)00112-7
  7. H. Nikawa et al. (2004). Lactobacillus reuteri in bovine milk fermented decreases the oral carriage of mutans streptococci. International journal of food microbiology, 95(2), 219-223. DOI : 10.1016/j.ijfoodmicro.2004.03.006
  8. A. Haukioja et al. (2006). Oral adhesion and survival of probiotic and other lactobacilli and bifidobacteria in vitro. Oral microbiology and immunology, 21(5), 326-332. DOI : 10.1111/j.1399-302X.2006.00299.x
  9. FAO/WHO. (2001). Evaluation of health and nutritional properties of powder milk with live lactic acid bacteria. Report from FAO/WHO Expert Consultation.
  10. E. Furrie. (2005). Probiotics and allergy. The Proceedings of the Nutrition Society, 64(4), 465-469. DOI : 10.1079/PNS2005466
  11. E. Isolauri, S. Salminen & A. C. Ouwehand. (2004). Microbial-gut interactions in health and disease. Probiotics. Best practice & research. Clinical gastroenterology, 18(2), 287-298. DOI : 10.1016/j.bpg.2003.10.008
  12. A. Aneja, F. El-Atat, S. I. McFarlane & J. R. Sowers. (2004). Hypertension and obesity. Recent Progress in Hormone Research, 169-205. https://doi.org/10.1210/rp.59.1.169
  13. K. Aihara, O. Kajimoto, H. Hirata, R. Takahashi & Y. Nakamura. (2005). Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. Journal of The American College of Nutrition, 24(4), 257-265. DOI : 10.1080/07315724.2005.10719473
  14. H. J. You1, S. H. Lee & G. P. Ko. (2015). Concepts and strategies of the human intestinal microbiome research. The Korean Journal of Public Health, 52(1), 11-19.
  15. R. Havenaar, B. Ten Brink & J. H. J. Huis in't Veld. (1992). Selection of strains for probiotic use. In Probiotics: The Scientific Basis. Probiotics, 209-224.
  16. Y. K. Kim. (2016). Probiotic development and market trends. BRIC View, T13, 1-10.
  17. S. K. Kim & S. D. Lim. (2018). Functionality and research trend of probiotics. Food Industry And Nutrition, 23(1), 18-24.
  18. P. W. O'Toole & J. C. Cooney. (2008). Probiotic bacteria influence the composition and function of the intestinal microbiota. Interdisciplinary perspectives on infectious diseases, 175285. DOI : 10.1155/2008/175285
  19. A. A. Amara & A. Shibl. (2015). Role of probiotics in health im- provement, infection control and disease treatment and management. Saudi pharmaceutical journal, 23(2), 107-114. DOI : 10.1016/j.jsps.2013.07.001
  20. J. M. Saavedra, N. A. Bauman, I. Oung, J. A. Perman & R. H. Yolken. (1994). Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet, 344(8929), 1046-1049. DOI : 10.1016/S0140-6736(94)91708-6
  21. E. Mastretta et al. (2002). Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. Journal of pediatric gastroenterology and nutrition, 35(4), 527-31. https://doi.org/10.1097/00005176-200210000-00013
  22. H. Szajewska et al. (2014). Use of probiotics for management of acute gastroenteritis: A position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. Journal of pediatric gastroenterology and nutrition, 58(4), 531-539. DOI : 10.1097/MPG.0000000000000320
  23. L. V. McFarland. (1994). A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. Journal of the American Medical Association, 271(7), 1913-1918. https://doi.org/10.1001/jama.1994.03510480037031
  24. M. Segarra-Newnham. (2007). Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii. The Annals of pharmacotherapy, 41: 1212-1221. DOI : 10.1345/aph.1K110
  25. V. Rosenfeldt, E. Benfeldt, N. H. Valerius, A. Pærregaard & K. F. Michaelsen. (2004). Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. The Journal of pediatrics, 145(5), 612-616. DOI : 10.1016/j.jpeds.2004.06.068
  26. V. Delcenserie, D. Martel, M. Lamoureux, J. Amiot, Y. Boutin & D. I. Roy. (2008). Immunomodulatory effects of probiotics in the intestinal track. Current Issues in Molecular Biology. 10, 37-54.
  27. B. Corthesy, H. R. Gaskins & A. Mercenier. (2007). Cross-talk between probiotic bacteria and the host immune system. The Journal of nutrition, 137(3 Suppl 2), 781S-790S. DOI : 10.1093/jn/137.3.781S
  28. E. J. Schiffrin, F. Rochat, H. Link-Amster & J. M. (1995). Aeschlimann & A. Donnet-Hughes. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. Journal of Dairy Science, 78(3), 491-497. DOI : 10.3168/jds.S0022-0302(95)76659-0
  29. F. Yan & D. B. Polk. (2010). Probiotics: progress toward novel therapies for intestinal disease. Current opinion in gastroenterology, 26(2), 95-101. DOI : 10.1097/MOG.0b013e328335239a
  30. K. Niedzielin, H. Kordecki & B. Birkenfeld. (2001). A controlled, doubleblind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. European journal of gastroenterology & hepatology, 13, 1143-1147. https://doi.org/10.1097/00042737-200110000-00004
  31. C. Stanton et al. (2001). Market potential for probiotics. The American Journal of Clinical Nutrition, 73(2), 476s-483s. DOI : 10.1093/ajcn/73.2.476s
  32. M. R. Sadzikowski, J. F. Sperry & T. D. Wilkins. (1977). Cholesterol-reducing bacterium from human feces. Applid and Environmental Microbiology, 34(4), 355-362. https://doi.org/10.1128/AEM.34.4.355-362.1977
  33. S. E. Gilliland, C. R. Nelson & C. Maxwell. (1985). Assimilation of cholesterol by Lactobacillus acidophilus. Applid and Environmental Microbiology, 49(2), 377-381. https://doi.org/10.1128/AEM.49.2.377-381.1985
  34. L. G. Ooi & M. T. Liong. (2010). Cholesterol-lowering effects of probiotics and prebiotics: A review of in vivo and in vitro findings. International Journal of Molecular Sciences. 11(6), 2499-2522. DOI : 10.3390/ijms11062499
  35. S. H. SH, Y. H. Kim, M. G. Kim, J. H. Kang & D. J. Kang. (2015). Cholesterol lowering effect of Enterococcus faecium ID9201 isolated from breast milk-fed Korean infant. Current Topic in Lactic Acid Bacteria and Probiotics, 3(2), 41-45. https://doi.org/10.35732/ctlabp.2015.3.2.41
  36. C. Scully & J. Greenman. (2012). Halitology (breath odour: aetiopathogenesis and management). Oral diseases, 18(4), 333-345. DOI : 10.1111/j.1601-0825.2011.01890.x
  37. C. Slocum, C. Kramer & C. A. Genco. Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis. (2016). Journal of internal medicine, 280(1), 114-128. DOI : 10.1111/joim.12476
  38. H. Sakagami & M. Tomomura. (2018). Dental Application of Natural Products. Medicines, 5(1), 21-28. DOI : 10.3390/medicines5010021
  39. R. Kobayashi, T. Kobayashi, F. Sakai, T. Hosoya, M. yamamoto & T. Kurita-Ochiai. (2017). Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis-accelerated periodontal disease. Scientific reports, 7(1), 545-554. DOI : 10.1038/s41598-017-00623-9
  40. J. H. Meurman. (2005). Probiotics: do they have a role in oral medicine and dentistry?. European Journal of Oral Sciences, 113(3), 188-196. DOI : 10.1111/j.1600-0722.2005.00191.x
  41. P. B. S. Bhadoria & S. C. Mahapatra. (2011). Prospects, technological aspects and limitations of probiotics - a worldwide review. European Journal of Food Research & Review, 1(2), 23-42.
  42. J. D. Hillman. (2002). Genetically modified Streptococcus mutans for the prevention of dental caries. Antonie van Leeuwenhoek, 82, 361-366. https://doi.org/10.1023/A:1020695902160
  43. L. Nase. et al. (2001). Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Research, 35(6), 412-420. DOI: 10.1159/000047484
  44. C. Stecksen-Blicks, I. Sjostrom & S. Twetman. (2009). Effect of long-term consumption of milk supplemented with probiotic lactobacilli and fluoride on dental caries and general health in preschool children: a cluster-randomized study. Caries Research, 43(5), 374-381. DOI: 10.1159/000235581
  45. M. O. Lexner, S. Blomqvist, G. Dahlen & S. wetman. (2010). Microbiological profiles in saliva and supragingival plaque from caries-active adolescents before and after a short-term daily intake of milk supplemented with probiotic bacteria - a pilot study. Oral Health & Preventive Dentistry, 8(4), 383-388.
  46. H. Yli-Knuuttila, J. Snäll. K. Kari & J. H. Meurman. (2006). Colonization of Lactobacillus rhamnosus GG in the oral cavity. Oral Microbiology and Immunology, 21(2), 129-131. DOI : 10.1111/j.1399-302X.2006.00258.x
  47. T. Taipale, K. Pienihakkinen, P. Alanen, J. Jokela & E. Soderling. (2013). Administration of Bifidobacterium animalis subsp. lactis BB-12 in early childhood: a post-trial effect on caries occurrence at four years of age. Caries research, 47(5), 364-372. DOI : 10.1159/000348424
  48. M. Stensson et al. (2014). Oral administration of Lactobacillus reuteri during the first year of life reduces caries prevalence in the primary dentition at 9 years of age. Caries research, 48(2), 111-117. DOI : 10.1159/000354412
  49. E. Caglar, S. C. Kavaloglu, O. O. Kuscu, N. Sandalli, P. L. Holgerson & S. Twetman. (2007). Effect of chewing gums containing xylitol or probiotic bacteria on salivary mutans streptococci and lactobacilli. Clinical Oral Investigations, 11(4), 425-429. DOI: 10.1007/s00784-007-0129-9
  50. E. Caglar, S. K. Cildir, S. Ergeneli, N. Sandalli & S. Twetman. (2006). Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets. Acta odontologica Scandinavica, 64(5), 314-318. DOI: 10.1080/00016350600801709
  51. H. J. Busscher, A. F. J. M. Mulder & H. C. van der Mei. (1999). In vitro adhesion to enamel and in vivo colonization of tooth surfaces by Lactobacilli from a bio-yoghurt. Caries Research, 33(5), 403-404. DOI: 10.1159/000016541
  52. E. K. Kim, Y. S. Kim, H. J. Kwon & Y. K. Lee. (2009). The Effect of Lactobacillus on Growth Suppression of Streptococcus Mutans and Streptococcus Sobrinus and Pro-biotic Effect of Yogurt. Korean Journal of Oral and Maxillofacial Pathology, 33(3), 167-174. DOI :
  53. W. Teughels, M. Van Essche, I. Sliepen & M. Quirynen. (2008). Probiotics and oral healthcare. Periodontol 2000, 48, 111-147. DOI : 10.1111/j.1600-0757.2008.00254.x
  54. D. N. Riccia et al. (2007). Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease. Oral Diseases, 13(4), 376-85. DOI: 10.1111/j.1601-0825.2006.01291.x
  55. H. Shimauchi et al. (2008). Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study. Journal of Clinical Periodontology, 35(10), 897-905. DOI : 10.1111/j.1600-051X.2008.01306.x
  56. G. Mayanagi et al. (2009). Probiotic effects of orally administered Lactobacillus salivarius WB21-containing tablets on periodontopathic bacteria: a double-blinded, placebo-controlled, randomized clinical trial. Journal of Clinical Periodontology, 36(6), 506-13. DOI: 10.1111/j.1600-051X.2009.01392.x
  57. R. T. Zahradnik, I. Magnusson, C. Walker, E. McDonell, C. H. Hillman & J. D. Hillman. (2009). Preliminary assessment of safety and effectiveness in humans of ProBiora3, a probiotic mouthwash. Journal of Applied Microbiology, 107(2), 682-690. DOI : 10.1111/j.1365-2672.2009.04243.x
  58. J. P. Burton et al. (2013). Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial. Journal of medical microbiology, 62(Pt 6), 875-884. DOI : 10.1099/jmm.0.056663-0
  59. R. M. Karuppaiah, S. Shankar, S. K. Raj, K. Ramesh, R. Prakash & M. Kruthika. (2013). Evaluation of the efficacy of probiotics in plaque reduction and gingival health maintenance among school children-A Randomized Control Trial. Journal of International Oral Health, 5(5), 33-37.
  60. M. S. Kang, B. G. Kim, J. Chung, H. C. Lee & J. S. Oh. (2006). Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds. Journal of Clinical Periodontology, 33(3), 226-232. DOI: 10.1111/j.1600-051X.2006.00893.x
  61. K. Hatakka et al. (2007). Probiotics reduce the prevalence of oral candida in the elderly-a randomized controlled trial. Journal of Dental Research, 86(2), 125-130. DOI: 10.1177/154405910708600204
  62. D. Li et al. (2014). Efficacy and safety of probiotics in the treatment of Candida‐associated stomatitis. Mycoses, 57(3), 141-146. DOI : 10.1111/myc.12116
  63. K. H. Ishikawa et al. (2015). A multispecies probiotic reduces oral Candida colonization in denture wearers. Journal of Prosthodontics, 24(3), 194-199. DOI : 10.1111/jopr.12198
  64. E. Kraft-Bodi, M. R. Jorgensen, M. k. Keller, C. Kragelund & S. Twetman. (2015). Effect of Probiotic Bacteria on Oral Candida in Frail Elderly. Journal of dental research. 94(9), 181S-186S. DOI : 10.1177/0022034515595950
  65. R. N. Husni, S. M. Gordon, J. A. Washington & D. L. Longworth. (1997). Lactobacillus bacteremia and endocarditis: review of 45 cases. Clinical infectious diseases, 25(5), 1048-1055. https://doi.org/10.1086/516109
  66. M. A. De Groote, D. N. Frank, E. Dowell, M. P. Glode & N. R. Pace. (2005). Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. The Pediatric Infectious Disease Journal, 24(3), 278-280. https://doi.org/10.1097/01.inf.0000154588.79356.e6
  67. M. Hedberg, P. Hasslof, I. Sjostrom, S. Twetman & C. Stecksen-Blicks. (2008). Sugar fermentation in probiotic bacteria-an 46 in vitro study. Oral microbiology and immunology, 23(6), 482-5. DOI : 10.1111/j.1399-302X.2008.00457.x